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Abstract
Introduction:

Orthodontic tooth movement requires the precise coordination of a

multitude of biological factors in order for proper bone remodeling to occur. Cytokines,
such as Interleukin-6 (IL-6), play a critical role in the communication necessary for both
bone resorption and bone apposition. IL-6 reacts with receptor proteins, such as soluble
IL-6 receptor (sIL-6R), on target cells in order to transmit signals important to both
osteoclast and osteoblast activities. Soluble glycoprotein 130 (sgp130), on the other
hand, acts as a natural inhibitor to IL-6 activity. The purpose of this investigation was to
evaluate the levels of IL-6, sIL-6R, and sgp130 in the gingival crevicular fluid (GCF) of
human teeth undergoing orthodontic forces on both the tension and compression sides in
the initial stages of orthodontic tooth movement. Methods: GCF samples were obtained
from 9 healthy orthodontic patients [5 males, 4 females, age range 11 to 31 years (mean
17.445 years)] just prior to initial wire placement (0.012 or 0.014 Nickel Titanium
archwire) with fixed orthodontic appliances. GCF samples were then collected 1, 6, and
24 hours after orthodontic force application. Patients returned in 5-7 weeks for a 2nd visit
and orthodontic re-activation. GCF samples were again collected immediately before
orthodontic activation, as well as 1, 6, and 24 hours after force application. Sampling
sites included the mesiobuccal and distolingual of an experimental tooth, as well as the
mesiobuccal of a control. GCF volumes were assessed with a Periotron 6000 (OraFlow,
Smithtown, New York), while a Bradford assay was performed to obtain protein levels.
Processing was carried out with a multiplex bead-based Luminex assay to detect IL-6,
sgp130, and sIL-6R levels in the GCF samples.

Results:

GCF volumes were

significantly higher in the experimental samples at both the initial (p=0.009) and recall
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visits (p=0.055). The greatest difference between GCF volumes for the experimental and
control sites was after 6 hours of orthodontic activation (p=0.02). Relative to the control
site, GCF IL-6 levels were significantly elevated for the mesiobuccal experimental site at
6 (p=0.001) and 24 hours (p=0.004) post-activation, whereas the IL-6 levels for the
distobuccal experimental site were only elevated at 24 hours post-activation (p=0.034).
GCF sgp130 levels were elevated for the mesiobuccal experimental site at 1, 6, and 24
hours post-activation relative to both the distobuccal experimental site (p=0.005,
p=0.012, p=0.001) and the control site (p=0.005, p=0.001, p=0.000). Similarly, GCF
sIL-6R levels were also elevated for the mesiobuccal experimental site at 1, 6, and 24
hours post-activation relative to both the distobuccal experimental site (p=0.035,
p=0.029, p=0.001) and the control site (p=0.037, p=0.006, p=0.006).

Conclusions:

GCF volumes increase in a time-dependent fashion after orthodontic forces are applied to
a tooth. Meanwhile, IL-6 levels in the GCF of orthodontically treated teeth increase
earlier than previously reported.

In the present study, IL-6 levels peaked at

approximately 6 hours post-activation. Additionally, sgp130 and sIL-6R levels in the
GCF are elevated throughout the first 24-hour post-activation period in orthodontic tooth
movement. While there was a definitive difference in protein levels between opposing
sides of the experimental teeth, further research is needed to differentiate the levels of IL6, sgp130, and sIL-6R on the compression and tension sides during orthodontic tooth
movement.
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Introduction
The study of bone remodeling was introduced in 1892 when German surgeon,
Julius Wolff, proposed that a transformation of both the internal and external bone
architecture occurs in response to prolonged stresses acting upon it (Frost, 2004). Since
that time, Wolff’s Law has been updated, modified, and expounded upon as researchers
continue to explore the complex field of bone biology.

An understanding of bone

remodeling is of particular interest to the profession of orthodontics.
Unperturbed, the native pattern of alveolar bone remodeling maintains a
homeostatic state.

The introduction of orthodontic treatment, however, disrupts the

equilibrium between bone apposition and bone resorption (Wise and King, 2008). When
orthodontic forces are applied to a tooth, they are transmitted to the periodontal ligament
(PDL) and adjacent alveolar bone. These forces, in turn, initiate a complex cascade of
events that result in the remodeling of the surrounding bone and eventual movement of
the tooth (Masella and Meister, 2006).

While the sequence of events at the tissue and

cellular levels of bone remodeling is well described, there remains a lack of
comprehensive understanding in the coordination of biochemical events at the molecular
level (Krishnan and Davidovitch, 2006). As such, there have been numerous studies that
have sought to further elucidate the molecular biology of bone remodeling during
orthodontic tooth movement.
In order to examine the molecular biology involved, a cellular understanding of
tooth movement is prerequisite. Osteoclasts are the primary bone resorbing cells in the
body, whereas osteoblasts are the primary bone forming cells.

A large number of

osteoclasts are recruited to the resorptive front during tooth movement (Rygh, 1974;
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Rody et al., 2001). As the tooth begins to move into the resorbed area, osteoblasts
proliferate and begin to secrete the precursors of new bone in the vacated area (King et
al., 1991; Roberts and Chase, 1981). Cycling between osteoclast and osteoblast activity,
the body must maintain a type of equilibrium in order to obtain efficient bone remodeling
during tooth movement.
While there are numerous interconnected systems in place that control the levels
of mature osteoclasts and osteoblasts active during bone remodeling, one predominate
pathway uses the cytokine family interleukin-6 (IL-6) as a signal transducer (Liu et al.,
2006).

Most importantly, IL-6 plays a critical role in the differentiation of both

osteoclasts and osteoblasts. Osteoclasts are derived from hematopoietic precursors in the
bone marrow, whereas osteoblasts are mesenchymal in origin (Manolagas, 1998).
Regardless of the cell’s origin, however, IL-6 type cytokines stimulate the differentiation
of the respective precursors into osteoblasts and osteoclasts (Blanchard et al., 2009). IL6 also interacts with other factors that are critically involved with bone homeostasis,
including the receptor activator of nuclear factor kappa-β (RANK)/receptor activator of
nuclear factor kappa-β ligand (RANKL)/osteoprotegerin (OPG) system, sex steroids,
prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-α, parathyroid hormone (PTH), IL11, and IL-1 (Liu et al., 2006). The natural inhibitor of these IL-6 signaling responses is
soluble glycoprotein 130 (sgp130) (Jostock et al., 2001).
While IL-6 has been extensively studied in other models of bone metabolism, the
investigation of the role of IL-6 during orthodontic tooth movement is relatively limited.
A convenient and non-invasive method to study molecules involved with tooth
movement is gingival crevicular fluid (GCF) analysis. Using this approach, the presence
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of many inflammatory factors has been identified, and the role these factors play in
orthodontic tooth movement has become more clearly understood (Ren and Vissink,
2008; Kavadia-Tsatala et al., 2002).

While the increased levels of IL-6 during

orthodontic tooth movement have been confirmed by GCF analysis (Uematsu et al.,
1996), a definitive temporal pattern has yet to be established. Furthermore, a comparison
between levels of IL-6 and the natural inhibitor, sgp130, has not been examined during
orthodontic tooth movement. The goal of this research, therefore, is to gain a better
understanding of IL-6, sgp130, and sIL-6R by determining whether a clear relationship
exists between their respective levels in bone remodeling, and by establishing a temporal
pattern of their production relative to initial orthodontic force application. Understanding
the relationship between orthodontic mechanics and the levels of IL-6 and sgp130 could
assist the clinician with providing optimal treatment. Additionally, since tooth movement
is a reliable model of overall bone metabolism, the results of this study will aid in more
clearly understanding somatic bone remodeling and repair. Furthermore, orthodontic
tooth movement and periodontal disease involve similar factors, and knowledge of the
cytokines involved in both processes may lead to an increased comprehension of the
complications involved with tooth movement such as loss of attachment and external
apical root resorption. Lastly, future research may provide the clinician with novel
techniques that make use of the complex role of IL-6 in orthodontic tooth movement.
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Literature Review
Orthodontic Tooth Movement
At first glance, it may appear that orthodontic tooth movement can be explained
by simple physics: a force is applied to a tooth until friction is overcome and the tooth
begins to move. Whereas this may explain the interface between the tooth and the
orthodontic appliance, it does not address the biological mechanisms involved.
Orthodontic tooth movement is a unique phenomenon where a solid object moves
through a solid medium. Therefore the biological intricacies involved with this type of
movement are novel and not entirely understood. As orthodontic forces are applied, the
mechanical loading within the system increases, and a complex cascade of biological
events lead to the remodeling of the surrounding tissues and eventual movement of the
tooth (Masella and Meister, 2006).
Theories of Orthodontic Tooth Movement
Historically, there have been several major theories of orthodontic tooth
movement, essentially revolving around two themes; namely, the periodontal ligament
and the alveolar bone. Presently, the most widely accepted theory explaining orthodontic
tooth movement is referred o as the pressure tension theory.
Pressure Tension Theory. According to the pressure tension theory, whenever a
tooth is subjected to an orthodontic force, areas of pressure and tension are created within
the periodontal ligament space. The periodontal ligament is compressed on the side
opposite of the force causing an increase in pressure, whereas the periodontal ligament on
the same side of the force increases in tension (Midgett et al., 1981). The changes in
pressure and tension within the periodontal ligament space initiate cellular changes
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produced by chemical messengers. On the pressure side, there is a decrease in cellular
replication as a result of vascular constriction, whereas on the tension side, there is an
increase in cellular replication because of the stimulation afforded by the stretching of the
fiber bundles of the periodontal ligament (Midgett et al., 1981).
Contemporary Pressure Tension Theory.

In 2008, Henneman proposed a

theoretical model that modified and updated the pressure-tension theory. This model
divides tissue and cellular responses to force application into four stages: (1) matrix
strain and fluid flow, (2) cell strain, (3) cell activation and differentiation, and (4) tissue
remodeling (Henneman, 2008).
Stage 1. The first stage occurs when tooth movement is initiated by the increased
mechanical loading of an orthodontic force. The initial movement of the tooth within the
periodontal ligament space results in a positive strain on the bone apposition side of the
periodontal ligament (Reitan, 1951). The side of bone apposition is often referred to as
the tension side in the pressure-tension theory but may be more accurately described as
the appositional side. This positive strain creates a stretching of the collagen fibers
connecting the tooth to the bone (Rygh et al., 1986; Melsen, 1999), which in turn, can
activate residing periodontal cells such as osteoblasts and fibroblasts. The side opposite
of the appositional side, on the other hand, undergoes a negative strain within the
periodontal ligament (Reitan, 1951), and is commonly referred to as the pressure side.
This term, however, can be somewhat misleading as the collagen fibers on this side
actually relax upon force application due to the negative strain (Melsen, 1999; Binderman
et al., 2002). Therefore, it may be more accurately referred to as the resorptive side. As
negative strain occurs on the resorptive side, the fluid within the periodontal ligament
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space undergoes an almost immediate fluid flow (Henneman, 2008). The fluid flow on
both the appositional and resorptive sides may activate entrapped osteocytes within the
bone through canaliculi (Weinbaum et al., 1994; Cowin et al., 1995; Mak et al., 1997).
This concept is often referred to as fluid shear stress theory and is supported by both in
vitro data (Klein-Nulend et al., 1995c; Ajubi et al., 1996; Owan et al., 1997; Westbroek
et al., 2000; Tan et al., 2006) and in vivo data (Pitsillides et al., 1995; Turner et al., 1995,
Knothe Tate et al., 2000).
Stage 2.

Cell strain is the next step in the response to orthodontic tooth

movement. Collagen fiber tension and fluid flow cause deformation of periodontal
ligament cells through a network of cell-matrix attachments (Beertsen et al., 1997;
Davidovitch, 1991). These cells include both fibroblasts and osteoblasts. This strain is
then transferred within the cell by the focal adhesion complex to the cytoskeleton and
protein kinases that initiate intracellular signaling pathways (Hynes, 1992; Wang and
Thampatty, 2006).

These pathways stimulate the production of mediators such as

interleukins, nitric oxide, and prostaglandins (Davidovitch et al., 1988; Alhashimi et al.,
2001; Bakker et al., 2003; Mullender et al., 2004; Tang et al., 2006; Klein-Nulend et al.,
1995b; Westbroek et al., 2000) that activate several types of cells.
Stages 3 & 4. The last two stages occur simultaneously and in conjunction with
one another.

The mediators released by the activated periodontal cells stimulate

osteocytes and a variety of periodontal ligament cells including osteoblasts, fibroblasts,
and osteoclast-precursors (Henneman, 2008). Osteocytes play a key role in both the
resorptive and apposition sides. On the appositional side, activated osteocytes release
mediators, which stimulate precursors in the periodontal ligament to differentiate into
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active osteoblasts (Dereka et al., 2006). Meanwhile, osteocytes release cytokines, which
stimulate the differentiation of precursors into osteoclasts on the resorptive side (Yoo et
al., 2004). These osteoclast associated regulating cytokines have been shown in vitro and
in vivo to include colony-stimulating factor, receptor activator of nuclear factor kappa β
ligand (RANKL), osteoprotegerin (OPG), and bone morphogenic proteins (Nomura and
Takano-Yamamoto, 2000; Zhao et al., 2002; Kurata et al., 2006; Shiotani et al., 2001).
After osteoclast differentiation has begun, the osteoclasts are stimulated by
osteoblast and osteocyte released osteopontin to begin attaching to the bone surface by
specific integrins (Gay and Weber, 2000).

These attached osteoclasts undergo a

morphological change and differentiate internally into functional zones. The clear zone
isolates the bone surface; the body of the osteoclast contains an extensive lysosomal
system; and the ruffled border is the site of actual bone resorption (Hill, 1998). It is at
this site that hydrogen ions are released to dissolve the bone, and enzymes resorb residual
organic matrix (Teitelbaum et al., 1997; Phan et al., 2004). As the bone undergoes
resorption, space is created to allow movement in the direction of force application.
The appositional side, meanwhile, is undergoing bone formation that is mediated
by the production of alkaline phosphatase, osteocalcin, and other non-collagenous
proteins (Matsuda et al., 1998; Ozaki et al., 2005; Yang et al., 2006). These cytokines
likely stimulate the production and differentiation of osteoblasts which are the primary
cells associated with bone deposition. While not the focus of this review, it is important
to note that the degradation and production of extracellular matrix material also plays an
important role in orthodontic tooth movement.

The periodontal fibroblasts react in a

similar way as osteoblasts in that they react to a number of mediators, including
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prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming growth factor-β
(Nahm et al., 2004; Apajalahti et al., 2003; Takahashi et al., 2003, 2006; Ingman et al.,
2005; Owan et al., 1997; Howard et al., 1998; You et al., 2000; Yamaguchi et al., 2004).
Molecular Level of Tooth Movement
As discussed, orthodontic tooth movement is a complex process involving many
types of cells, mediators, and a complex system of cytokine cascades. It is important to
understand tooth movement on a cellular and molecular level in order to better control
and modify it clinically.
Cell types.

Bone remodeling is primarily a function of three cell types:

osteoclasts, osteoblasts, and osteocytes. Osteoclasts are multinucleated giant cells of
hematopoietic origin that have the capacity to resorb mineralized tissue.

These

descendants of the monocyte-macrophage lineage can be distinguished by their polarized
morphology and ruffled border. Osteoblasts, on the other hand, are derived from bone
marrow mesenchymal stem cells and are the principal cells of bone matrix apposition.
These bone-forming cells are progressively transformed into osteocytes as their own
secretion products trap the cells. Bone remodeling is the result of the coordinate and
interactive effects of these three osteogenic cell types. Through cell-cell contacts and
soluble factors, a complex balance between bone resorption and bone apposition is
maintained.
Cytokines. As in most biological functions, cytokines are the soluble factors
primarily involved in the coordinate activities of osteogenic cells. While typically only
present in nanomolar-to-picomolar concentrations (Heinrich et al., 1998), cytokines
regulate the proliferative, differentiative, and maturation events in most cells throughout
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the body. Unlike hormones, which are stored for later secretion, cytokines are usually
rapidly synthesized locally and then immediately secreted when stimulated (Heinrich et
al., 1998). When the two communicating cells are in close proximity, the rapidity of
synthesis and secretion can make cytokine detection difficult.
Cytokines are often described as pleiotropic due to the variety of effects they can
stimulate depending on the nature of the target cell (Simpson et al., 1997). Some
cytokines may elicit agonistic or antagonistic effects on the same target cell depending on
the surrounding factors. In addition to the pleiotropism that they may exhibit, cytokines
often display overlapping biological activities and may even share the same receptors
(Simpson et al., 1997).

A plethora of cytokines are involved in bone metabolism

including RANK, RANKL, OPG, bone morphogenetic proteins (BMPs), interleukin 1
(IL-1), interleukin 6 (IL-6), interleukin 11 (IL-11), and TNF-α amongst many others
(Krishnan & Davidovitch, 2009).
Osteogenic Cytokines.

A system of cytokines of particular significance in

understanding the relationship between osteoclastogenesis and osteoblastogenesis in
tooth movement is the OPG/RANKL/RANK system. The discovery of osteoprotegerin
was the first step in understanding this complex interaction.

The molecule was

discovered independently by two groups conducting contrasting experiments. While
studying therapeutic utilities of TNF receptor-related molecules, the Amgen, Inc. group
stumbled upon a relatively innocuous protein whose overexpression caused marked
osteopetrosis in rats (Simonet et al., 1997). It was found that this was due to a decrease
in osteoclasts, indicating that OPG played a clear role in regulating osteoclastogenesis.
The Snow Brand Milk Group, meanwhile, was systematically searching for a theoretical
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molecule fulfilling the role that OPG occupies now when they discovered the same
protein as the Amgen, Inc. group (Yasuda et al., 1998). OPG has since undergone
significant research to further characterize the protein (Khosla, 2001).
RANK/RANKL/OPG System. The discovery of OPG warranted the search for
an osteoclast differentiation factor expressed on osteoblastic cells that was essential for
osteoclast development.

The identification of RANKL as this protein was quickly

realized by the two previously mentioned groups (Lacey et al., 1998; Yasuda et al.,
1998). RANKL was shown to play a key role in osteoclast differentiation stimulation,
osteoclast activity, and the inhibition of osteoclast apoptosis (Malyankar et al., 2000;
Lacey et al., 1998; Fuller et al., 1998). RANK had previously been identified as the
receptor for RANKL, so its involvement in osteoclastogenesis regulation became readily
apparent (Anderson et al., 1997).
The interaction between the three proteins is actually quite simple. Osteoblasts
produce both osteoclastogenesis-stimulating RANKL and osteoclastogenesis-inhibiting
OPG (Kearns et al., 2008; Khosla, 2001). If both RANKL and OPG are released by the
osteoblastic cell, then OPG binds to RANKL that effectively inhibits the osteoclastogenic
activity of RANKL (Schneeweis et al., 2005). If OPG is not present, however, then
RANKL is free to bind to its natural receptor, RANK (Nakagawa et al., 1998; Kearns et
al., 2008). The RANK receptor is located on osteoclast precursor cells, and when bound
by RANKL, it promotes the differentiation of the cell into a mature osteoclast (Khosla,
2001; Kearns et al., 2008). Through this system, bone remodeling is regulated by a
balance between RANK-RANKL binding and OPG production (Theoleyre et al., 2004).
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Interleukin-6 and Orthodontic Tooth Movement
As explained, bone tissue remodeling results from the coordinate activities of
osteoblasts, osteoclasts, and the RANK-OPG system. An important integrating factor in
all of these elements is interleukin-6 (IL-6), a protein that functions as a cytokine in a
myriad of biological functions including bone metabolism. Derived primarily in the bone
marrow from osteoblastic cells, IL-6 is unique in that it may function in contradictory
roles depending on the target cell (Kwan Tat et al., 2004; Liu et al., 2006). In fact, with a
role in both bone apposition and bone resorption, IL-6 is a critical factor in skeletal
homeostasis as well as bone remodeling (Manolagas and Jilka, 1995; Martin et al., 1998;
Suda et al., 1999).
Signaling through the IL-6 Receptor. IL-6 signal transduction begins with the
binding of IL-6 to IL-6Rα, a glycoprotein that lacks intrinsic signaling properties
(Franchimont et al., 2005). The binding of IL-6 to IL-6Rα, in turn, stimulates the
association of the IL-6/IL-6Rα complex with the signal-transducing receptor,
glycoprotein 130 (gp130) (Kamimura et al., 2003). Since bonding is between a pair of
IL-6/IL-6Rα complexes and two gp130 molecules, this newly formed complex is
hexameric in structure (Franchimont et al., 2005). While IL-6Rα is often a membrane
bound protein, the soluble form (sIL-6Rα) may initiate the activation of the signal
transduction pathway as well (Franchimont et al., 2005). This agonistic process, referred
to as transsignaling, can been seen on cells expressing only gp130, and allows IL-6 to
function in most parts of the body (Franchimont et al., 2005; Jones et al., 2001;
Kamimura et al., 2003). In contrast to sIL-6Rα, soluble gp130 (sgp130) acts in an
antagonistic manner and may take part in turning off gp130 signaling (Kamimura et al.,
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2003; Franchimont et al., 2005). According to Franchimont (2005), the levels of sgp130
present in the bone microenvironment in physiological conditions or in inflammation
states are currently unknown.
After the activation of the gp130 complex is initiated, signal transduction
continues via the activation of Janus kinases (JAK), which leads to the activation of one
of the two major signaling pathways: the mitogen-activated protein kinase (MAPK)
cascade, or the signal transducers and activators of transcription (STAT) cascade (Kwan
Tat et al., 2004).

These two major pathways are dependent on one another both

qualitatively and quantitatively (Franchimont et al., 2005). With the use of knock-in
experimentation, it has also been shown that silencing of one pathway will lead to an
exaggerated activation of the remaining signaling pathway (Ernst & Jenkins, 2004;
Heinrich et al., 2003).
IL-6 Type Cytokines.

Since gp130 has been identified as the IL-6 signal

transducer, other cytokines have been found to use gp130 as a receptor subunit as well
(Kamimura et al., 2003). Cytokines using gp130 as a signal transducer are commonly
referred to as IL-6 Type Cytokines and include IL-11, IL-27, IL-31, ciliary neurotrophic
factor (CNTF), cardiotrophin-1 (CT-1), leukemia-inhibitory factor (LIF), cardiotrophinlike cytokine (CLC), neuropoietin (NP), and oncostatin M (OSM) (Blanchard et al.,
2009). Similar to the complex formed by IL-6 and IL-6Rα, most IL-6 Type Cytokines
bind to a ligand-specific receptor prior to interacting with the gp130 receptor subunit
(Kamimura et al., 2003).
Since all IL-6 Type Cytokines use gp130 as a signal transducer, there is a large
amount of redundancy in biological activities among the included cytokines (Kamimura
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et al., 2003). For example, all known IL-6 Type Cytokines can initiate the production of
acute-phase proteins (APPs) (Kamimura et al., 2003). Several in vivo studies have
indicated, however, that some effects are specific to individual IL-6 Type Cytokines and
that each of these cytokines could have a predominant role in a particular
pathophysiological situation (Blanchard et al., 2009).
IL-6 Signal Orchestration Model. As has been discussed, IL-6 acts upon a
multitude of different cells throughout the body, and may even initiate different signal
pathways in the same cell type. In addition to this, there may be similar IL-6 Type
Cytokines acting in coordination with the IL-6 induced signaling pathways. Using both
in vivo and in vitro experimentation, Kamimura et al. (2003) found that gp130 can even
simultaneously activate contradictory signals in a given target cell.

It is theorized that

the overall balance of these distinct signals could determine the final biological outputs
by a given ligand in a target cell (Kamimura et al., 2003). This theory is termed the
signal orchestration model (Hirano et al., 1997; Hirano, 1999; Hirano and Fukada, 2001).
This theory may also aid in the explanation of how a pleotropic cytokine like IL-6 can
exert multiple functions in a variety of cells. The target cells may be exposed to a variety
of cytokine signaling factors.

The complex interaction among different signaling

networks can influence the activation state of a certain pathway, which will then
modulate the balance of the signaling, and effectually determine the biological outputs
(Kamimura et al., 2003).

With regards to orthodontic tooth movement, the signal

orchestration model provides an explanation for the involvement of IL-6 in both bone
resorption and bone apposition.
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Effects of Interleukin-6 on Bone Resorption.

Derived from hematopoietic

precursors in the bone marrow (Roodman, 1996), osteoclasts are the primary cells
involved in bone resorption. These highly specialized, multinucleated cells dissolve
crystalline hydroxyapatite and degrade organic bone matrix rich in collagen fibers by use
of specialized machinery associated with the osteoclasts unique cell structure (Vaananen
et al., 2000). Osteoclast activity may either be modulated directly or indirectly via a host
of regulatory factors including growth factors, hormones, and cytokines such as IL-6 (Liu
et al., 2006).
IL-6 can indirectly stimulate osteoclastic activity by increasing interactions
between osteoblasts and osteoclasts via the RANK/RANKL/OPG system (Blanchard et
al., 2009). Interestingly, the protein will stimulate osteoclast activity when co-cultured
with osteoblasts, but has no osteoclastic activity in an osteoclast culture devoid of
osteoblasts (Kwan Tat et al.¸ 2004). In fact, some studies have shown that IL-6 may have
an inhibitory role on osteoclast differentiation and bone resorption when obtained from
purified osteoclast precursors (Blanchard et al., 2009). Other studies have shown that
along with IL-11 and LIF, IL-6 can stimulate the osteoblastic secretion of several
downstream effectors such as RANKL, which then activate osteoclast activity and
differentiation (Blanchard et al., 2009). In order for RANKL secretion to be stimulated,
however, sIL-6R must be present due to the low levels of IL-6R expressed on osteoblasts
(Liu et al., 2006; Blanchard et al., 2009). Furthermore, TNF-α, IL-1, and PGE2 may
stimulate the osteoblastic production of IL-11, LIF, and IL-6, which will further amplify
the osteoclastic signal (Blanchard et al., 2009).

In addition to its effects on RANKL

secretion, IL-6 has been shown in vitro to both increase RANK expression on osteoclasts
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and decrease OPG secretion by osteoblasts when combined with sIL-6R (Liu et al.,
2006). The net result of this stimulation on the RANK/RANKL/OPG system is increased
osteoclastic activity. O’Brien et al. (2000) and Kwan Tat et al. (2004), however, have
reported a decrease in RANK expression and an increase in OPG secretion when IL-6
and sIL-6R are introduced in combination. Recently, IL-6 has been shown to induce
osteoclast formation by a RANKL-independent mechanism, but the method by which it
does so is still unclear (Kudo et al., 2003).
Effects of Interleukin-6 on Bone Apposition. Osteoblasts, the principal bone
apposition cells, originate from multipotent mesenchymal stem cells of the bone marrow,
which also give rise to fibroblasts, chondrocytes, adipocytes, and muscle cells
(Manolagas, 1998; Liu et al., 2006; Aubin, 1998). IL-6 promotes osteogenic lineage
commitment of the mesenchymal marrow cells by stimulating their differentiation into
osteoblastic precursors (Liu et al., 2006; Blanchard et al., 2009). Due to the low levels of
IL-6R on the osteoblast cell surface, sIL-6R or LIF must be present in combination with
IL-6 in order for the stimulation of mesenchymal cells to occur (Blanchard et al., 2009;
Liu et al., 2006). IL-6 then stimulates the further differentiation and development of the
osteoblastic precursor cells into functional osteoblasts by activation of the JAK/STAT
pathway (Liu et al., 2006; Iwasaki et al., 2008; Blanchard et al., 2009; Manolagas, 1998;
Itoh et al., 2006). Lastly, IL-6 will initiate apoptosis in mature osteoblasts (Li et al.,
2008).
In addition to its role in the stimulation of osteoblast differentiation, IL-6 has
recently been shown to directly suppress osteoclastogenesis by inhibition of the RANK-
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signaling pathway (Yoshitake et al., 2008; Duplomb et al., 2008). IL-6 accomplishes this
by diverting precursor cells into the macrophage lineage (Duplomb et al., 2008).
Gingival Crevicular Fluid
In recent years, gingival crevicular fluid (GCF) has been used as a medium to
measure a variety of molecules and bacteria present in both the oral cavity and the
periodontal ligament space.

GCF is an osmotically mediated exudate found in the

gingival sulcus that tends to increase in volume with inflammation and greater capillary
permeability (Yamaguchi, 2009).

While GCF is primarily composed of serum, the

composition can be modified by the surrounding gingival tissue and any bacteria present
in the area (Cimasoni, 1983). As such, GCF can be found to contain a variety of
substances including immunoglobulins, microorganisms, toxins, cells, and lysosomal
enzymes (Yamaguchi, 2009).

Recently, it has been observed that markers in bone

remodeling and destruction can be found with the GCF as well (Lamster and Novak,
1992). It has been shown to accurately reflect the immune and inflammatory reactions
arising from both periodontitis and orthodontic force application (Lamster, 1992;
McCulloch, 1994; Ren et al., 2002; Ren et al., 2007).
GCF Levels of IL-6, sgp130, and sIL-6R. While many studies have used GCF
levels to examine bone remodeling during active periodontal disease, more research is
needed to examine the same markers during orthodontic force application.

Several

cytokines and growth factors have, however, been shown to have a strong correlation
with orthodontic force application (Uematsu et al., 1996; Grieve et al., 1994; Lowney et
al., 1995). To this point, the GCF levels of IL-6 during orthodontic tooth movement have
been examined in several previous studies. Uematsu et al. (1996) found a peak increase
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in IL-6 after 24 hours of force application in canine retraction cases. Since that time,
several studies have replicated the result of human IL-6 peak activation after 24 hours
(Ren et al., 2007; Ren et al., 2002; Zhang and Ren, 2001). None of these reports,
however, examined time points between 1 and 24 hours post-orthodontic activation. Yao
et al. (2003), on the other hand, found that IL-6 levels were elevated in the GCF for at
least 72 hours after orthodontic force application was induced. Two studies showed that
IL-6 levels were not significantly elevated in adult orthodontic patients (Ren et al., 2002;
Zhang and Ren, 2001). At this time, neither the natural inhibitor of IL-6, spg130, nor the
soluble receptor for IL-6, sIL-6R, have been examined in GCF levels from an orthodontic
or periodontal perspective.
Summary
Orthodontic tooth movement is not a simple process and involves a plethora of
molecules both known and unknown at this time. This process is most easily introduced
by examining the four stages of tooth movement as introduced by Henneman (2008). It
is during the initial stages of this process that IL-6 plays a critical role in both bone
apposition and bone resorption. Sgp130, on the other hand, is an important antagonist to
the signaling of the cytokine IL-6. The current study examined the roles that these two
proteins play in orthodontic tooth movement. The null hypothesis was that the levels of
IL-6 in GCF peak at a shorter interval than previously examined in orthodontic tooth
movement. The ratio of IL-6 to sgp130 levels in the GCF was also expected to exhibit a
temporal pattern. This knowledge will allow orthodontists to be more effective in their
clinical decisions during force application and may allow for future research to examine
possibilities in orthodontic tooth movement acceleration.
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Methods and Materials
Study Population
GCF samples were collected from nine orthodontic patients [5 males, 4 females,
age range 11 to 31 years (mean 17.445 years)] treated at the University of Nevada, Las
Vegas School of Dental Medicine. All patients were approached during the screening
appointment, and proper consent was obtained prior to beginning orthodontic treatment.
Research protocol and consent forms were approved by the Office of Research Integrity –
Human Subjects.
All patients were treatment planned to receive orthodontic treatment with fixed
appliances. The study inclusion criteria were: no self-reported use of anti-inflammatory
medications, good periodontal health (generalized probing depths ≤ 3mm and no
radiographic evidence of periodontal bone loss), and the presence of one or more teeth
that did not require immediate orthodontic movement. Patients were excluded from the
study based on the following criteria: presence of periodontal disease and/or moderate to
severe gingivitis, only minimal required tooth movement, diabetes, self-reported use of
anti-inflammatory medication within the last 30 days, history of bleeding problems, use
of tobacco, and/or poor oral hygiene.
Data Collection
Pre-treatment records including photographs, panoramic and cephalometric
radiographs, and study models were obtained for each patient. Prior to treatment, a
detailed periodontal examination was also performed.

Probing depths, bleeding on

probing (BOP), and a plaque index (PI) were recorded at both initial and recall
appointments. One test tooth per patient was selected based on the amount of predicted
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movement while also taking into consideration the ease of accurate sample collection. Of
the nine selected experimental teeth, five were maxillary lateral incisors, three were
mandibular lateral incisors, and one was a maxillary central incisor.

Tension and

compression sites for each test tooth were predicted based on preliminary study models.
One control tooth per patient was selected based on the individual treatment plans by
determining teeth that did not require immediate orthodontic bonding. Of the nine
selected control teeth, one was a maxillary lateral incisor, one was a maxillary canine,
one was a mandibular canine, two were mandibular incisors, two were mandibular
premolars, and two were maxillary premolars. Control teeth were not bonded with
orthodontic appliances either before or during the duration of the study.
Initial GCF samples were obtained prior to the bonding of any orthodontic
appliances at three separate sites for each patient.

Samples were taken on the

mesiobuccal and distolingual of the experimental teeth as well as the mesiobuccal of the
control teeth. Prior to sampling, the teeth were isolated with cotton rolls and gently dried
with air. Thereafter, Periopaper (Oraflow, Smithtown, New York) was carefully inserted
into the sulci to collect the GCF from each site for approximately 90 seconds. After
removal from the sulci, each Periopaper was placed in a Periotron 6000 (Oraflow,
Smithtown, New York) to measure the amount of GCF fluid obtained. This procedure
was carried out three times per sampling site, and the combined Periopapers were
immediately placed in a single vial of 200 µL of 1X phosphate buffered saline (PBS). At
each time point, samples were collected from three sites: the mesiobuccal of the test
teeth, the distolingual of the test teeth, and the mesiobuccal of the control teeth. Samples
were then placed in a standard freezer for interim storage until they could be moved on
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the same day to a -20°C freezer for final storage until assayed. The number of freeze
thaw cycles of the samples was kept to a minimum.
After an initial sampling procedure, orthodontic appliances were bonded on each
patient. Orthodontic forces were then applied by use of a 0.012 or 0.014 Nickel Titanium
archwire. One hour after initial orthodontic force application, a second set of GCF
samples was collected in the same manner as the initial samples. This procedure was
repeated again after 6 and 24 hours of orthodontic force application.
Patients returned for recall appointments after 5-7 weeks.

A periodontal

examination was performed to record probing depths, BOP, and PI. Exclusion criteria
were reevaluated for each patient, and no patients were eliminated from the study based
on the aforementioned criteria. Another sampling procedure was carried out prior to any
changes in orthodontic treatment. New orthodontic forces were then applied by use of a
new 0.016 or 0.018 Nickel Titanium archwire for seven of the nine patients. The initial
archwire was removed and retied for the remaining two patients. Samples were again
collected 1, 6, and 24 hours after the orthodontic forces were reactivated.
Calibration of Periotron 6000
The Periotron 6000 was calibrated by adding 14 sequentially increasing known
fluid volumes (0.1-1.4 µL) of fetal bovine serum (FBS) to Periopaper strips that were
then placed in the Periotron. The numerical readings given by the Periotron per volume
were recorded. Each volume was tested three times to minimize error. The mean value
per volume was calculated and a calibration curve was plotted using MasterPlex 2010
(Hitachi Solutions) analysis software. A fourth polynomial regression equation was
formulated from the mean values, and was used to calculate the GCF volume absorbed to
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the periopaper. The three volumes obtained per sample site were added together to
calculate total GCF volume per sample.
GCF Protein Concentration
GCF protein concentration was determined by a commercially available protein
assay reagent based upon the Bradford method of protein concentration determination
(Bradford, 1976). In brief, 20 µl of sample was combined with 275 µl of Protein Dye
Reagent (Bio-Rad, Hercules, CA) following the microtiter plate assay directions as
suggested by the manufacturer. After a 10-minute room temperature incubation with
shaking, the absorbance at 595 nm was determined using a SpectaMax Plus (Molecular
Devices, Sunnyvale, CA) microplate spectrophotometer. Bovine serum albumin was
used as the protein standards for generation of the standard curve and unknown
concentrations were calculated. All standards and samples were assayed in duplicate.
IL-6, sIL-6R, and sgp130 Levels in GCF
IL-6, sIL-6R, and sgp130 levels in GCF were determined by MILLIPLEX MAP
assays (Millipore, Billercia, MA) according to manufacturer’s instructions. In preparation
for the multiplex assay, the GCF samples were thawed on ice and centrifuged at 1000xg
for 10 minutes. Two hundred microliters of assay buffer were added to each well of the
microtiter filter plate. The plate was then placed on a plate shaker for 10 minutes at room
temperature. The assay buffer was then removed from each well by vacuum. Standards
and control were added to the appropriate wells (25 µL). 25 µL of assay buffer was then
added to the sample wells only, followed by the addition of 25 µL of matrix solution to
the background, standards, and control wells. Samples (25 µL) were then added to the
appropriate wells.

	
  

Finally, 25 µL of mixed beads were added to each well.
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microtiter filter plate was then incubated overnight on a plate shaker at 4°C. After
incubation, all liquid was removed from the plate by gentle vacuuming. The plate was
then washed 3 times with 200 µL/well of wash buffer with vacuuming between each
wash. Detection antibodies (50 µL) were added and the plate was sealed and incubated
on a plate shaker for 1 hour at room temperature. At that point, StreptavidinPhycoerythrin (50 µL) was added to each well and the plate was incubated for an
additional 30 minutes at room temperature.

After the incubations, the liquid was

removed by vacuum filtration and plate was washed 3 times with 200 µL/well of wash
buffer with vacuum filtration between each wash. This was followed by the addition of
100 µL of sheath fluid to each well. The plate was then placed on the plate shaker for 5
minutes in order to re-suspend the labeled beads. The plate was then analyzed on a
Luminex 200 (Luminex Corp. Austin, TX). Raw data was exported from the Luminex
instrument and standard curves and unknowns were analyzed using MasterPlex 2010
(Hitachi Solutions) analysis software.
Statistical Analysis
The means for the GCF volume, total protein levels, IL-6 levels, sgp130 levels,
and the sIL-6R levels for both experimental sites and the control site were compared
using Student’s t test using Microsoft Excel and SPSS 16. Significance was accepted for
a p < 0.05.
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Results
Bone remodeling associated with orthodontic tooth movement is a complex
process involving a myriad of cytokines.

During the initial stages of tooth movement,

IL-6 plays a critical role in both osteoclast and osteoblast activity. In order to initiate the
signaling cascade, IL-6 binds to the target cells via a membrane bound receptor complex
that may include sIL-6R. Meanwhile, sgp130 acts as a natural inhibitor for the signaling
of the cytokine IL-6. The present study examined the levels of IL-6, sgp130, and sIL-6R
in the GCF throughout the initial stages of orthodontic tooth movement. In coordination
with these efforts, the volume and protein concentration of GCF secreted during
orthodontic tooth movement was also monitored.
Patient and Sample Characteristics
Five males and four females ranging from 11 to 31 years of age volunteered for
participation in the study (Table 1). Initial GCF samples were obtained prior to the
bonding of any orthodontic appliances at three separate sites for each patient. Samples
were taken on the mesiobuccal and distolingual of the experimental teeth as well as the
mesiobuccal of the control teeth. Periopaper (Oraflow, Smithtown, New York) was
carefully inserted into the sulci to collect the GCF from each site for approximately 90
seconds. After removal from the sulci, each Periopaper was placed in a Periotron 6000
(Oraflow, Smithtown, New York) to measure the amount of GCF fluid obtained. This
procedure was carried out three times per sampling site, and the Periopaper samples were
immediately combined in a single vial of phosphate buffered saline. At each time point,
samples were collected from three sites:
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the mesiobuccal of the test teeth, the

	
  

distolingual of the test teeth, and the mesiobuccal of the control teeth. Two sets of
samples were not collected due to patient scheduling (Table 2).
Table 1.
Sex
Male
Female

Patient Characteristics
n
Age
5
Mean
4
Min
Max

n
17.445
11.167
31.250

Table 2. Summary of GCF Samples Collected
Post-activation Test Site
Visit
(hours)
MB (n)
Initial
0
9
1
9
6
9
24
9
Recall
0
9
(5-7 weeks)
1
8
6
9
24
8
Total
70

Test Site
DL (n)
9
9
9
9
9
8
9
8
70

Control Site
MB (n)
9
9
9
9
9
8
9
8
70
= 210

Gingival Crevicular Fluid Volume
The Periotron readings for each Periopaper were converted into GCF volume (µL)
by use of a standard curve. The 4-parameter standard curve was created by placing
sequentially known volumes of fetal bovine serum onto pieces of Periopaper, which were
then placed into the Periotron to produce a reading (Figure 1). Recorded Periotron
readings for each Periopaper were then converted into GCF volume for analysis and total
GCF for each sample was calculated by adding together the individual readings for each
of the 3 Periopapers that constituent a single sample.
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Figure 1. Conversion of Periotron Readings to GCF Volume (µL)
The GCF volumes were analyzed to determine any temporal patterns during
orthodontic tooth movement. The distribution of measured GCF volumes for control and
experimental sites (MB and DL) at both the initial (first) and recall (second) appointment
are depicted in Figure 2. Control GCF volume ranged from 0.1 µL to 1.9 µL, while
experimental GCF volumes ranged from 0.1 µL to 4.3 µL. Mean GCF values were
calculated for each. The difference between the mean GCF volumes of the experimental
samples from the initial visit (1.13±0.50 µL) and the mean GCF volumes of the
experimental samples from the recall visit (1.05±0.50 µL) was not statistically significant
(p=0.25). Additionally, there was not a statistically significant difference between the
control sample mean GCF volumes from the initial (0.80±0.22 µL) and recall
appointments (0.85±0.32 µL; p=0.26). When comparing the mean GCF volumes of the
experimental samples to the mean GCF volumes of the control samples, however, there
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was a statistically significant difference for both the initial visit (p=0.009) and the recall
visit (p=0.05) (Figure 2).

Figure 2. Total GCF Volume Collected During First and Second Visit
There is no statistical difference between the amount of GCF collected
between the first and second visit for both the control and experimental
samples. There is, however, a significant increase in the amount of GCF
collected from experimental teeth versus control teeth at both the first and
the second visit (# p < 0.05).
When the mean GCF volumes for experimental samples were compared
according to the time since activation regardless of visit, there was a statistically
significant increase in volume at 6 hours relative to all other time points (p<0.05). At
both the 6 hour (p=0.02) and 24 hour (p=0.03) time points, there was also a statistically
significant difference between the experimental and control mean GCF volumes. There
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was no statistically significant difference among any of the control mean GCF volumes
regardless of sample time (Figure 3).

Figure 3. GCF Volumes Reported in Hours Since Activation
For experimental mean GCF volumes, there was a statistically significant
increase at the 6-hour time point versus all other experimental time points
(# p < 0.05). There was a statistical significant difference in mean GCF
volumes for experimental and control samples at both 6 hours (* p=0.02)
and 24 hours (* p=0.03). Note that at 1 hour, p=0.08, and although
increased was not considered statistically significant as significance was
set at p < 0.05.
Gingival Crevicular Fluid Protein Levels
The protein levels in each GCF sample were determined by the assay method first
developed by Bradford (1976). Known quantities of bovine serum albumin were used as
proteins standards and the protein concentrations were plotted against the observed
absorbance at 595 nm (Figure 4).

Protein concentrations in the samples were

extrapolated from the standard curve. Total protein was calculated by multiplying the
determined sample concentration (mg/ml) by the 0.2 ml sample volume.

Figure 5

illustrates the distribution of protein levels detected in the collected samples. Control
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Figure 4. Standard Curve Obtained for Bradford Assay
Known quantities of BSA were measured at absorbance of 595 nm on a
spectrophotometer (Molecular Devices SpectraMax) in order to create a
standard curve. The Bradford analysis was performed in duplicate with 20
µL of sample in order to determine the protein concentration (µg/mL) in
the previously eluted samples.
total protein levels ranged from 3 µg to 85 µg, while experimental GCF total protein
levels ranged from 4 µg to 175 µg. Mean total protein values were calculated for each.
When comparing the mean total protein amounts for the experimental samples (MB and
DL), there was not a significant difference between total protein levels from the first
(36.55±27.59 µg) and second visits (35.24±20.31 µg).

In contrast, there was a

statistically significant difference between the control mean total protein levels from the
first (23.66±12.79 µg) and second visits (35.36±19.40 µg; p=0.005). Likewise, when
comparing mean total protein levels between the control and experimental samples, there
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Figure 5. Total Protein Levels By Visit
Statistically significant differences were found between the experimental
and control samples from the first visit (* p < .03), as well as between the
control samples of the first and second visit (# p < .01). It was noted that
there was not a significant difference between the control and
experimental values from the second visit (+ p > 0.05).
was a statistically significant difference from samples obtained during the first visit (p =
0.028).

On the other hand, there was not a significant difference between the

experimental and control mean total protein levels from the samples obtained during the
second visit (Figure 5). Interestingly, when the mean total protein levels are combined by
visit, but separated by hours since activation, there is no significant difference between
the three sample sites at any time point (Figure 6).

	
  

29	
  

	
  

80
)g 70
60
€
	
  (
n
i 50
e
t 40
o
r
P
	
  l 30
at 20
o
T 10
0

Control
MB
DL

0

1

6

24

Sample	
  Time	
  (Hours)
Figure 6. Total Protein Levels in Hours Since Activation
No statistically significant difference with time for either control or
experimental
In addition to examining GCF volume and total protein levels, the protein
concentration in the GCF was calculated (total protein/ GCF volume) to ascertain if any
differences existed between the samples. Control GCF protein concentrations ranged
from 6 µg/µL to 102 µg/µL, while experimental GCF protein concentrations ranged from
7 µg/µL to 135 µg/µL. Mean protein concentration values were calculated for each.
When comparing the control to the experimental samples at the first or second visit, no
significant differences were detected. For both control (p=0.002) and experimental
(p=0.006) GCF protein concentrations, however, there was a significant increase at the
second visit (40.41±15.60 µg/µL, 37.46±15.38 µg/µL) compared to the first visit
(28.76±11.00 µg/µL, 29.39±13.80 µg/µL; Figure 7). When control and experimental
protein concentrations were examined by time since activation regardless of visit, no
statistically significant differences were found (Figure 8).
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Figure 7. Protein Concentration By Visit
Statistically significant differences were found between the first
and second visits for the control samples (# p < 0.003) and the
experimental samples (* p < 0.006). There was no statistically
significant difference between the control and experimental
samples at either visit.
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Figure 8. Protein Concentration in Hours Since Activation
No statistically significant difference with time for either control or
experimental
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IL-6, sgp130, and sIL-6R Levels
The purpose of the present study was to investigate and establish temporal
patterns of the levels of IL-6, sgp130, and sIL-6R in the GCF during orthodontic tooth
movement. Since the alveolar bone surrounding teeth undergoing orthodontic tooth
movement contains both sites of bone resorption and bone apposition, IL-6 levels (fg/µg
protein) were investigated on opposing sides (MB and DL) of the experimental teeth in
order to examine any differences in cytokine activity between the two sites. Both sample
sites were also compared to a control site in order to establish baseline activity for IL-6
for teeth not undergoing orthodontic tooth movement. Control GCF IL-6 concentrations
ranged from 8 fg/µg to 480 fg/µg, while experimental GCF IL-6 concentrations ranged
from 10 fg/µg to 795 fg/µg. Mean IL-6 protein concentration values were calculated for
each. The mean GCF IL-6 protein concentration for the MB of the experimental teeth
(83.85±74.73 fg/µg) was significantly higher than the mean GCF IL-6 protein
concentration for both the DL of the experimental teeth (49.10±45.55 fg/µg; p=0.025)
and the control site (50.67±50.07 fg/µg; p=0.032; Figure 9a). In order to investigate the
temporal pattern of the mean IL-6 levels in the GCF, the samples were sorted by sample
site according to hours since activation. Relative to the control site, the mean IL-6 values
on the MB were significantly higher after both 6 hours (p=0.001) and 24 hours (p=0.004),
whereas there was only a significant difference at 24 hours on the DL (p=0.034; Figure
9b). Despite the elevated appearance of figure 9b at 1 hour for the MB site, there was no
statistical significance due to a high SEM. Figure 9c depicts individual mean IL-6 values
at each post-activation time point, and highlights the reason for an elevated SEM at the
MB site after 1 hour of activation. Mean IL-6 protein concentration levels appear to peak
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Figure 9a. Mean IL-6 Levels by Sample Site
While there was not a statistically significant difference between the control
and DL experimental site for mean GCF IL-6 levels, the MB experimental
site GCF IL-6 levels were significantly elevated relative to both the DL
experimental site and the control site (* p<0.04).

Figure 9b. Mean IL-6 Levels Reported in Hours Since Activation
There was a statistically significant increase in IL-6 levels at 6 hours (*p
< 0.002) and 24 hours (% p < 0.005) on the MB of the experimental teeth
relative to the control. There was also a statistically significant increase
in IL-6 levels on the DL of the experimental teeth at 24 hours (& p <
0.04). Lastly, there was a statistically significant difference in overall IL6 levels at 0 hours for both of the experimental sites relative to the control
(# p < 0.05). It is noted, however, that these measurements include the
second visit IL-6 protein levels which may influence the baseline.
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after approximately 6 hours of orthodontic activation. It must also be noted that there
was a statistically significant difference between both the MB and DL experimental sites
(p=0.035, p=0.046) relative to the control sites at 0 hours (Figure 9a).
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Figure 9c. Individual IL-6 Levels in Hours Since Activation
While the mean IL-6 levels appeared to be highest for the mesiobuccal at
1 hour, the results were not statistically significant due to a large standard
deviation. The results of this figure indicate that IL-6 levels peaked after 6
hours.
Since sgp130 has been shown to act as a natural inhibitor to IL-6 activity
(Franchimont et al., 2005; Jostock et al., 2001; Kamimura et al., 2003), mean sgp130
GCF levels (pg/µg protein) were also measured in order to establish a temporal pattern
relative to IL-6 levels. Control GCF sgp130 concentrations ranged from 0.2 pg/µg to 5.8
pg/µg, while experimental GCF sgp130 concentrations ranged from 2.0 pg/µg to 16.5
pg/µg. Mean sgp130 protein concentration values were calculated for each. The mean
GCF sgp130 protein concentration for the MB of the experimental teeth (6.16±2.55

	
  

34	
  

	
  

pg/µg) was significantly higher than the mean GCF sgp130 protein concentration for both
the DL of the experimental teeth (3.58±1.03 pg/µg; p=0.000) and the control site
(3.21±0.94 pg/µg; p=0.000; Figure 10a). The difference in mean GCF sgp130 levels
between the DL site of the experimental teeth and the control site was not statistically
significant (p=0.07; Figure 10a). In order to investigate the temporal pattern of the mean
sgp130 levels in the GCF, the samples were sorted by sample site according to hours
since activation. Mean sgp130 levels were significantly elevated at the MB experimental
site at 1 (p=0.005), 6 (p=0.001), and 24 hours (p=0.000) post-activation relative to the
control (Figure 10b). Similarly, Figure 10b shows that the mean sgp130 levels on the
MB experimental site were elevated at 1 (p=0.005), 6 (p=0.012), and 24 hours (p=0.001)
post-activation relative to the experimental DL site as well. There was no significant
difference for sgp130 levels between the control and DL samples.

Figure 10a. Mean sgp130 Levels by Sample Site
While there was not a statistically significant difference between the control
and DL experimental site for mean GCF sgp130 levels, the MB
experimental site GCF sgp130 levels were significantly elevated relative to
both the DL experimental site and the control site (* p<0.01).
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Figure 10b. Mean Sgp130 Levels Reported in Hours Since Activation
Sgp130 levels were elevated at the mesiobuccal experimental site at 1
hour, 6 hours, and 24 hours relative to both the control and distolingual
experimental sites (* p < 0.02).
Since sIL-6R often forms part of the receptor complex for IL-6 on the target cell,
it would be expected that sIL-6R may increase as IL-6 levels increase. In order to
investigate the relationship between IL-6 and sIL-6R, the levels of GCF sIL-6R (pg/µg
protein) were examined during orthodontic tooth movement as well. Control GCF sIL6R concentrations ranged from 0.3 pg/µg to 1.2 pg/µg, while experimental GCF sIL-6R
concentrations ranged from 0.4 pg/µg to 2.3 pg/µg. Mean sIL-6R protein concentration
values were calculated for each. The mean GCF sIL-6R protein concentration for the
MB of the experimental teeth (1.22±0.55 pg/µg) was significantly higher than the mean
GCF sIL-6R protein concentration for both the DL of the experimental teeth (0.65±0.27
pg/µg; p=0.000) and the control site (0.67±0.29 pg/µg; p=0.000; Figure 11a). In order to
investigate the temporal pattern of the mean IL-6 levels in the GCF, the samples were
sorted by sample site according to hours since activation. Similar to mean sgp130 levels,
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the mean GCF sIL-6R levels were significantly elevated on the MB of the experimental
site at 1 hour, 6 hours, and 24 hours post-activation relative to both the control (p=0.037,
p=0.006, p=0.006) and DL experimental sites (p=0.035, p=0.029, p=0.001).
Additionally, mean GCF sIL-6R levels from the experimental MB site were significantly
higher than the control and experimental DL sites at 0 hours post-activation (p=0.001,

sIL-‐6R	
  (pg/µg	
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p=0.003; Figure 11b).
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Figure 11a. Mean sIL-6R Levels by Sample Site
While there was not a statistically significant difference between the
control and DL experimental site for mean GCF sIL-6R levels, the MB
experimental site GCF sIL-6R levels were significantly elevated relative
to both the DL experimental site and the control site (* p<0.01).
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Figure 11b. Mean SIL-6R Levels Reported in Hours Since Activation
SIL-6R levels were elevated at the mesiobuccal experimental site at 0
hours, 1 hour, 6 hours, and 24 hours relative to both the control and
distolingual experimental sites (p < 0.04).
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Discussion
Gingival Crevicular Fluid Volume
The present study evaluated the changes in IL-6, sgp130, and sIL-6R in gingival
crevicular fluid (GCF) after the application of orthodontic force.

GCF samples were

collected at eight different time points over 5-7 weeks. At both the initial bonding
appointment and at the first recall appointment, baseline samples were collected. After
orthodontic force application, samples were then collected at three additional time points
(1, 6, and 24 hours) for each appointment.
Analysis of GCF volume results did not show a statistically significant difference
in GCF volumes between the first and second visit for either the control or experimental
groups. Comparison of the experimental GCF volumes to the control volumes, however,
clearly demonstrated increased GCF volumes associated with the experimental teeth.
While these results indicate that increased GCF volume may be used as suitable
biomarker for tissue remodeling during orthodontic treatment, previous reports in the
literature regarding orthodontic tooth movement and GCF volume have been conflicting.
Studies by both Tersin (1978) and Baldwin et al. (1999) reported an increase in GCF
volume during orthodontic tooth movement, whereas Miyajima (1991), Uematsu et al.
(1996), and Drummond et al. (2011) reported no statistically significant difference in the
GCF volumes of orthodontically treated teeth. The conflicting results may be due to a
difference in study design as well as the time points at which GCF volumes were
measured. The present study is the only study in which GCF volume was measured at
the 6-hour time point.
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Since there was not a statistically significant difference between the first and
second visit for GCF volumes within the same sample groups, further analysis of GCF
volume combined the two appointments and examined GCF volumes by hours since
activation (0, 1, 6, and 24 hours). With the exception of the 0-hour time point, all
experimental samples showed a higher GCF volume than the corresponding control
samples at every time point. In addition, the 6-hour time point showed a statistically
significant increase in GCF volume for experiment samples relative to all other
experimental time points. Previous studies on GCF volume during tooth movement have
not examined volumes after 6 hours of orthodontic force application. The increase in
GCF volume may be an early indicator of the inflammation associated with orthodontic
tooth movement, and an examination of GCF volumes at 6 hours after force application
may provide the optimal time for assaying the degree of inflammation associated with
tooth movement.
Total Protein Concentration
Since GCF volumes vary between samples, it is possible that total protein levels
may vary accordingly.

Thus, examining GCF protein concentration gives a more

accurate view of the protein levels in each sample.

The present study reported a

statistically significant increase in protein concentration between the first and second
visits for both the control group and the experimental group. There was, however, no
significant difference in protein concentration between the control and experimental
samples at either visit.

When examining the protein concentration relative to the time

since force activation, there was no statistically significant differences at any time point
for experimental or control groups.
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generalized increase in GCF protein concentration levels as orthodontic forces are
applied.
Interleukin-6, sgp130, and sIL-6R Levels
Orthodontic tooth movement is a complex process, which involves a delicate
balance of bone apposition and bone resorption. IL-6 has been shown to influence both
osteoblastic and osteoclastic activity, and thus, plays a critical role in orthodontic bone
remodeling (Liu et al., 2006). In fact, IL-6 can simultaneously generate both osteoclastic
and osteoblastic signals in a target cell through its receptor complex, IL-6Rα and gp130
(Kamimura et al., 2003).

While the soluble form of IL-6Rα, sIL-6R, may act

synergistically with IL-6 (Blanchard et al., 2009), the soluble form of gp130 , sgp130,
has been shown to act as a natural inhibitor to IL-6 activity (Jostock et al., 2001;
Kamimura et al., 2003; Franchimont et al., 2005). The present study examined the GCF
levels of IL-6, sgp130, and sIL-6R after orthodontic force application.
While previous studies have shown a peak in IL-6 levels during orthodontic tooth
movement after 24 hours (Uematsu et al., 1996; Ren et al., 2007; Ren et al., 2002; Zhang
and Ren, 2001), none of the studies examined IL-6 GCF levels between 1 and 24 hours
after orthodontic activation. The present study investigated an additional time point at 6
hours post-activation, as well as opposing sites (mesiobuccal and distolingual) on the
same experimental tooth. Opposing sites were chosen in order to measure possible
differences between the compression and tension sides of tooth movement. For most of
the experimental teeth, however, rotation was the primary predicted movement after
initial force activation, and as such, it was not possible to accurately designate either site
as the compression or tension side. Based off preliminary models, however, it was
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predicted that bone resorption would be more likely to occur on the mesiobuccal side of
the experimental teeth in seven of the nine patients. In the remaining two patients, it was
difficult to predict which site may undergo bone resorption. It must also be noted that the
possibility of contamination between the two opposing sites in the gingival crevice could
not be excluded.
The data from this study showed a statistically significant increase of
approximately two-fold for the mean IL-6 GCF levels at 6 and 24 hours on the
mesiobuccal of the experimental teeth relative to controls at the corresponding time
points. In fact, IL-6 levels appeared to peak after 6 hours of orthodontic activation on the
mesiobuccal of the experimental teeth.

Meanwhile, the IL-6 GCF levels on the

distolingual of the experimental teeth were significantly higher than controls at 24 hours.
There also appears to be a clear increase in IL-6 GCF levels on the distolingual of the
experimental teeth after orthodontic activation.
It must also be noted that while the mesiobuccal experimental IL-6 GCF levels
were significantly higher than the control samples at 0 hours, and the distolingual
experimental IL-6 GCF levels were significantly lower than the control samples at 0
hours, the measured protein levels were a combination of both the first and second visits.
Due to the nature of the Nickel Titanium orthodontic wires used in the study, that some
residual activation was still present at 0 hours of the second visit in some cases.
The results of this study indicate that the peak IL-6 levels may be earlier than
previously reported. While it was not possible to differentiate the compression and
tension sides of tooth movement, it would be expected that IL-6 levels would increase
regardless due to the involvement of IL-6 in both osteoclastic and osteoblastic activities.
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Since sgp130 has been found to be a natural inhibitor to IL-6 (Jostock et al., 2001;
Kamimura et al., 2003; Franchimont et al., 2005), it may be expected that GCF levels of
sgp130 would decrease as IL-6 levels increase. The present study, however, showed an
increase is sgp130 levels on the mesiobuccal of experimental teeth 1, 6, and 24 hours. It
may be that as IL-6 is produced, sgp130 levels gradually increase until an inhibitory
effect is produced on IL-6 activity. It may be predicted, in such a scenario, that sgp130
levels would continue to increase past the time constraints of the present study. At
present, there are no other published studies that have examined GCF levels of sgp130
during orthodontic tooth movement. Future studies may be able to solidify a stronger
relationship between the GCF levels of IL-6 and sgp130 during orthodontic tooth
movement by expanding the time line.
The mean concentration levels of sIL-6R were significantly elevated in the
mesiobuccal site of experimental teeth at all time points relative to the control and
distolingual sites.

IL-6 signal transduction typically occurs through a gp130/IL-6R

receptor complex (Kamimura et al., 2003). While the soluble form of gp130, sgp130,
acts as an antagonist to IL-6 activity (Jostock et al., 2001; Kamimura et al., 2003;
Franchimont et al., 2005), the soluble form of IL-6R, sIL-6R, may replace its membranebound counterpart in the receptor complex (Kamimura et al., 2003). As such, levels of
sIL-6R may be expected to increase as IL-6 activity increases as was seen in the present
study. If enough membrane bound IL-6R is present, however, sIL-6R would not be
necessary for IL-6 signal transduction. As with mean IL-6 concentration levels, it should
be noted that sIL-6R GCF levels were elevated in the mesiobuccal site at 0 hours as well.
It must be taken into consideration that since first and second visit samples were
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combined for the sake of analysis, continued activation of the Nickel Titanium
orthodontic wires may have elevated sIL-6R levels at the 0 hour time point of the second
visit.
For IL-6, sgp130, and sIL-6R, there was a statistically significant difference
between the mesiobuccal and distolingual experimental sites for most time points. While
it is difficult to accurately predict which site was undergoing bone resorption versus bone
apposition, it is clear that orthodontic forces affect protein levels on the compression and
tension sides to a different extent.
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Conclusions
1.

Gingival crevicular fluid volume increases after orthodontic forces are applied. In
the present study, GCF fluid volume peaked at 6 hours post-activation but remained
elevated at 24 hours post-activation.

2.

The IL-6 concentration levels in the GCF increase during orthodontic tooth
movement, with a peak at approximately 6 hours post-activation. While earlier
studies reported a peak at 24 hours, previous studies did not measure levels between
1 and 24 hours.

3.

Sgp130 and sIL-6R are detectable in the GCF during initial tooth movement. While
the concentration levels of both proteins increase after orthodontic forces are
applied, further research must be completed to establish a strong temporal pattern
relative to IL-6 levels.

4.

Orthodontic forces affect IL-6, sgp130, and sIL-6R protein levels on the
compression and tension sides to a different extent. Further research must be
completed in order to establish a strong relationship between the proteins and the
type of bone remodeling occurring.
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